Middle East Healthcare Company (4009.SR)
SAR 71.8
(2.28%)
SAR 71.8
(2.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.15 Million | 76.02 Million | 76.62 Million | -263.38 Million | 98.63 Million | 161.35 Million |
| Net Income | 180.17 Million | 81.21 Million | 19.23 Million | 99.67 Million | 95.28 Million | 172.24 Million |
| Depreciation & Amortization | 189.81 Million | 145.97 Million | 141.4 Million | 127.21 Million | 98.41 Million | 88.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -407.7 Million | -228.57 Million | -121.22 Million | -500.17 Million | -92.86 Million | -110.54 Million |
| Other non-cash items | 70.87 Million | 77.4 Million | 37.2 Million | 9.89 Million | -2.18 Million | -10.89 Million |
| Investing Cash Flow | -241.98 Million | -249.39 Million | -417.38 Million | -290.18 Million | -468.84 Million | -355.32 Million |
| Investments in PPE | -232.36 Million | -249.52 Million | -417.51 Million | -294.29 Million | -472.1 Million | -356.7 Million |
| Acquisitions | 380.54 Thousand | 131.23 Thousand | 125.9 Thousand | 480.67 Thousand | 3.25 Million | 1.38 Million |
| Investment purchases | -10 Million | - | - | - | - | - |
| Sales/Maturities of investments | 10 Million | - | - | - | - | - |
| Other Investing Activities | -10 Million | 127.84 Thousand | -827.34 Thousand | 3.62 Million | 2.46 Million | -355.32 Million |
| Financing Cash Flow | 237.65 Million | 160.84 Million | 351.98 Million | 516.6 Million | 379.87 Million | 127.13 Million |
| Debt repayment | -256.71 Million | -937 Million | -695.67 Million | -522.5 Million | -383.82 Million | -313.5 Million |
| Dividends payments | - | - | - | - | - | -184.08 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -157.93 Million | 1.09 Billion | 1.04 Billion | 1.03 Billion | 763.7 Million | 127.13 Million |
| Accounts receivables | -697.84 Million | -354.04 Million | -32.88 Million | -473.49 Million | -122.1 Million | -85.55 Million |
| Accounts payables | 132.56 Million | 124.12 Million | -59.92 Million | 21.9 Million | 66.7 Million | -3.53 Million |
| Inventory | 85.47 Million | 5.58 Million | -1.14 Million | -33.74 Million | -10.3 Million | -6.64 Million |
| Other working capital | 72.1 Million | -4.24 Million | -27.26 Million | -14.85 Million | -27.16 Million | -14.81 Million |
| Cash at beginning of period | 15.6 Million | 28.12 Million | 16.9 Million | 53.88 Million | 44.21 Million | 111.05 Million |
| Cash at end of period | 44.42 Million | 15.6 Million | 28.12 Million | 16.9 Million | 53.88 Million | 44.21 Million |
| Capital Expenditure | -232.36 Million | -249.52 Million | -417.51 Million | -294.29 Million | -472.1 Million | -356.7 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 28.82 Million | -12.52 Million | 11.21 Million | -36.97 Million | 9.66 Million | -66.83 Million |
| Free Cash Flow | -199.21 Million | -173.5 Million | -340.89 Million | -557.68 Million | -373.46 Million | -195.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 67.41 Million | 51.94 Million | 180.17 Million | 36.5 Million | 58.95 Million | 46.68 Million |
| Depreciation & Amortization | 53.26 Million | 51.33 Million | 189.81 Million | 49.6 Million | 45.4 Million | 48.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -117.63 Million | 44.78 Million | -407.7 Million | -138.39 Million | -235.41 Million | -386.13 Thousand |
| Other non-cash items | 67.24 Million | -9.39 Million | 70.87 Million | 31.88 Million | 59.96 Million | 20.36 Million |
| Investing Cash Flow | -77.26 Million | -37.87 Million | -241.98 Million | -56.84 Million | -35.34 Million | -79.7 Million |
| Investments in PPE | -99.08 Million | -37.87 Million | -232.36 Million | -54.17 Million | -25.54 Million | -79.79 Million |
| Acquisitions | 21.82 Million | 4400.00 | 380.54 Thousand | 87 Thousand | 195.03 Thousand | - |
| Investment purchases | - | - | -10 Million | - | - | - |
| Sales/Maturities of investments | - | - | 10 Million | - | - | - |
| Other Investing Activities | -115.13 Million | -37.87 Million | -10 Million | -2.75 Million | -10 Million | 84.45 Thousand |
| Financing Cash Flow | 85.98 Million | -119.62 Million | 237.65 Million | 56.46 Million | 73.93 Million | 47.91 Million |
| Debt repayment | -161.74 Million | -113.88 Million | -256.71 Million | -60.07 Million | -105.06 Million | -96.08 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 85.98 Million | -182.87 Million | -157.93 Million | -47.59 Million | 178.99 Million | 143.99 Million |
| Accounts receivables | -217.21 Million | 217.21 Million | -697.84 Million | -245.18 Million | -211.75 Million | -26.72 Million |
| Accounts payables | -35.08 Million | -116.01 Million | 132.56 Million | 22.67 Million | -29.89 Million | 26.72 Million |
| Inventory | -7 Million | -2.45 Million | 85.47 Million | 39.18 Million | 11.82 Million | 15.61 Million |
| Other working capital | 47.55 Million | -53.95 Million | 72.1 Million | 44.93 Million | -5.59 Million | -16 Million |
| Cash at beginning of period | 21.67 Million | 44.42 Million | 15.6 Million | 65.21 Million | 97.71 Million | 14.04 Million |
| Cash at end of period | 72.3 Million | 21.67 Million | 44.42 Million | 44.42 Million | 65.21 Million | 97.71 Million |
| Capital Expenditure | -99.08 Million | -37.87 Million | -232.36 Million | -54.17 Million | -25.54 Million | -79.79 Million |
| Effect of forex changes on cash | - | - | - | 1.00 | - | - |
| Net cash flow / Change in cash | 50.63 Million | -22.74 Million | 28.82 Million | -20.79 Million | -32.5 Million | 83.67 Million |
| Free Cash Flow | -57.17 Million | 96.87 Million | -199.21 Million | -74.58 Million | -96.63 Million | 35.67 Million |
6573
GRAMMY
BNDSY
SOMANYCERA
4570
INPOY